Please assess the completion status of the following clinical trial:

Trial Title: NanoSpectrometer Biomarker Discovery and Confirmation Study

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_CONTROL
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Adults age 18 and over with diagnosed Stage 1 Lung Cancer (cases)~* Adults age 18 and over without Lung cancer (type 1 controls)~* Adults age 18 and over who live in the same environment as the cases (type 2 controls)~Exclusion Criteria N/A

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Stage 1 Lung Cancer (Case) (Type: None): These are the participants with identified stage 1 lung cancer.
- Type 1 Control (Type: None): These are participants who have similar clinical characteristics as our cases, but do not have any history of cancer.
- Type 2 Control (Type: None): These are housemates of the participants with stage 1 lung cancer (cases).

Based on this trial design, predict the completion outcome and termination type (if applicable).